These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25758345)
1. Artificial human Met agonists based on macrocycle scaffolds. Ito K; Sakai K; Suzuki Y; Ozawa N; Hatta T; Natsume T; Matsumoto K; Suga H Nat Commun; 2015 Mar; 6():6373. PubMed ID: 25758345 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells. Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646 [TBL] [Abstract][Full Text] [Related]
4. MET Activation by a Macrocyclic Peptide Agonist that Couples to Biological Responses Differently from HGF in a Context-Dependent Manner. Miao W; Sakai K; Imamura R; Ito K; Suga H; Sakuma T; Yamamoto T; Matsumoto K Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322054 [TBL] [Abstract][Full Text] [Related]
5. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Papa E; Weller M; Weiss T; Ventura E; Burghardt I; Szabó E Cell Death Dis; 2017 Dec; 8(12):3210. PubMed ID: 29238047 [TBL] [Abstract][Full Text] [Related]
6. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels. Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042 [TBL] [Abstract][Full Text] [Related]
7. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1. Niemann HH Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275 [TBL] [Abstract][Full Text] [Related]
9. Cyclic Peptide-Based Biologics Regulating HGF-MET. Sato H; Imamura R; Suga H; Matsumoto K; Sakai K Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121208 [TBL] [Abstract][Full Text] [Related]
10. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells. Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901 [TBL] [Abstract][Full Text] [Related]
11. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment. Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536 [TBL] [Abstract][Full Text] [Related]
12. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398 [TBL] [Abstract][Full Text] [Related]
13. Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells. Accornero P; Miretti S; Bersani F; Quaglino E; Martignani E; Baratta M PLoS One; 2012; 7(9):e44982. PubMed ID: 23028720 [TBL] [Abstract][Full Text] [Related]
14. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages. Lee YJ; Park HJ; Woo SY; Park EM; Kang JL J Pharmacol Exp Ther; 2014 Sep; 350(3):563-77. PubMed ID: 24939420 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320 [TBL] [Abstract][Full Text] [Related]
16. Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist. Miao W; Sakai K; Ozawa N; Nishiuchi T; Suzuki Y; Ito K; Morioka T; Umitsu M; Takagi J; Suga H; Matsumoto K Sci Rep; 2018 Nov; 8(1):16492. PubMed ID: 30405161 [TBL] [Abstract][Full Text] [Related]
17. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide. Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Seol DW; Chen Q; Zarnegar R Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700 [TBL] [Abstract][Full Text] [Related]
19. Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Day RM; Cioce V; Breckenridge D; Castagnino P; Bottaro DP Oncogene; 1999 Jun; 18(22):3399-406. PubMed ID: 10362361 [TBL] [Abstract][Full Text] [Related]
20. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling. Landgraf KE; Santell L; Billeci KL; Quan C; Young JC; Maun HR; Kirchhofer D; Lazarus RA J Biol Chem; 2010 Dec; 285(51):40362-72. PubMed ID: 20937841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]